Details for 2018730518

Up to date per 03.04.2026

Actions

Title / Product Name

ANTI-FGFR2 ANTIKÖRPER IN KOMBINATION MIT CHEMOTHERAPEUTISCHEN MITTELN ZUR BEHANDLUNG VON KREBS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018730518

EP Publication Number

3624837

E-Number

1818220

Language

PCT Number

US18032757

Publication Date

25.03.2020 A

30.07.2025 B1

Registration Date

30.07.2025

AT Publication Date

15.08.2025

Application Date

15.05.2018

Registration Number

Priorities

16.05.2017

201762507053 P

06.11.2017

201762581992 P

IPC

A61K 39/00 20060101AFI20181123BHEP

Maximum Duration of Protection

15.05.2038

Owner

Five Prime Therapeutics, Inc.111 Oyster Point Boulevard South San Francisco, CA 94080US

Representative

No representatives present

Inventor

COLLINS, Helen L.111 Oyster Point Boulevard South San Francisco California 94080US

HNATYSZYN, James111 Oyster Point Boulevard South San Francisco California 94080US

XIANG, Hong111 Oyster Point Boulevard South San Francisco California 94080US

ZHANG, Xiang111 Oyster Point Boulevard South San Francisco California 94080US

Information about Fees